BioSistemika Head of Software Engineering Anže Videnič will speak at the plenary stage of MSS Biotechevents in Bled on September 15, exploring why regulated science may be particularly well prepared for AI.
Public source
Publisher name
Public post
𝐃𝐨𝐧’𝐭 𝐭𝐫𝐮𝐬𝐭 𝐀𝐈 – 𝐚𝐮𝐝𝐢𝐭 𝐢𝐭. That is the message our Head of Software Engineering, Anže Videnič, will bring to the plenary stage at MSS Biotechevents in…
Company
BioSistemika
High-quality digital solutions for laboratories
- Industry
- Biotechnology
- Location
- Ljubljana, SI
- Company size
- 11–50 employees
About BioSistemika
BioSistemika specializes in custom software development, digitalization consulting, and development of laboratory software products. Over the past 10 years, we have worked with many laboratory instrument manufacturers and delivered software products that were tailored to our customer needs. We have completed several in vitro diagnostic (IVD) projects and non-IVD software projects for our customers for which we developed entire software product suites, starting from requirements, design specification, coding, and testing. For IVD, we are working in accordance with ISO 13485 and IEC 62304. We have vast experience in software-hardware integrations and are supporting standardization efforts that enable interoperability. BioSistemika also has immense experience with resolving compatibility with laboratory equipment, other software systems, connections between coding languages, big data storage, and analysis. We aim to empower scientists with professional software that has an excellent user experience. Years of experience in customizing software solutions gained us trusted partners. We cooperate with leading Life Science companies such as Gilson, Agilent, Alifax, ADInstruments, 4titude, and many others. BioSistemika has also consulted the most prominent companies about setting up a digitalization strategy. We help to implement it and build all the missing links by integrating existing software solutions or building new ones. We have successfully collaborated in multiple grant-funded R&D projects as well as lead international consortia. We have an experienced project management team and back office at our disposal, capable of coordinating and managing complex R&D activities, administration as well as the subsequent commercialization stages.
See moreLatest activity
Latest activity from BioSistemika
3 signals
Presence & Recognition
BioSistemika was named one of the Future 760 Louveenia companies at the Future500 Forum held alongside the Strategic Forum in Bled.
Research & Knowledge
BioSistemika published an article by Head of Engineering Anže Videnič examining the challenges and gaps in laboratory software for regulated markets.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Intelliseq
Intelliseq Head of Bioinformatics, Paweł Sztromwasser, will present iFlow - Clinical NGS and PGx Data Analysis Platform at the XIX Symposium of the Polish Bioinformatics Society in Poznań on Thursday, September 17, 2026.
Presence & Recognition
Ardigen
Ardigen will be presenting at BioTechX Europe in Basel, 6-8 October, discussing AI-enabled target discovery and phenotypic profiling.
Presence & Recognition
BIA Separations Inc.
BIA Separations Inc. is hosting a live presentation by CEO Ales Strancar on plasma fractionation at the MSS Biotechevents 2026 event on September 14th 2026.
Presence & Recognition
Menten AI
Menten AI Associate Director of Protein Design Stephan Kudlacek will speak at the Boulder Peptide Symposium on September 30th, 2026, on the topic of machine learning applied to oral and macrocyclic peptide design.
Presence & Recognition
Cloud9